Clinical trials sponsored by BeBetter Med Inc

Phase breakdown

Conditions studied

Recruiting trials led by BeBetter Med Inc

• A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
  NCT07544056 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）
  NCT07368608 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
  NCT06706713 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations
  NCT06514027 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
  NCT06998108 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials is BeBetter Med Inc recruiting for?

BeBetter Med Inc is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.